Obesity and Benign Prostatic Hyperplasia: Clinical Connections, Emerging Etiological Paradigms and Future Directions

Journal of Urology

Volumn 182, Issue 6 SUPPL., 2009, Pages

  Parsons, J Kellogg ^a   Sarma, Aruna V ^b   McVary, Kevin ^c   Wei, John T ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Department of Epidemiology ^*  (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

metabolic syndrome X; obesity; prostate; prostatic hyperplasia; urination disorders

Indexed keywords

ARTICLE; BODY MASS; CLINICAL FEATURE; DISEASE ASSOCIATION; HUMAN; METABOLIC SYNDROME X; OBESITY; PATHOPHYSIOLOGY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; PROSTATE SURGERY; RISK FACTOR; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

AGE FACTORS; HUMANS; MALE; METABOLIC SYNDROME X; MOTOR ACTIVITY; OBESITY; PREVALENCE; PROSTATIC HYPERPLASIA; RISK FACTORS; URINATION DISORDERS;

EID: 72149084621     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2009.07.086     Document Type: Article

References (43)

1. Wei J.T., Calhoun E., Jacobsen S.J., et al. Urologic Diseases in America project: benign prostatic hyperplasia. J Urol 173 (2005) 1256
2. Engstrom G., Henningsohn L., Steineck G., et al. Self-assessed health, sadness and happiness in relation to the total burden of symptoms from the lower urinary tract. BJU Int 95 (2005) 810
3. Engstrom G., Henningsohn L., Walker-Engstrom M.L., et al. Impact on quality of life of different lower urinary tract symptoms in men measured by means of the SF 36 questionnaire. Scand J Urol Nephrol 40 (2006) 485
4. Taylor B.C., Wilt T.J., Fink H.A., et al. Prevalence, severity, and health correlates of lower urinary tract symptoms among older men: the MrOS study. Urology 68 (2006) 804
5. Parsons J.K., Mougey J., Lambert L., et al. Lower urinary tract symptoms increase the risk of falls in older men. BJU Int 104 (2009) 63
6. Parsons J.K. Modifiable risk factors for benign prostatic hyperplasia and lower urinary tract symptoms: new approaches to old problems. J Urol 178 (2007) 395
7. Haffner S., and Taegtmeyer H. Epidemic obesity and the metabolic syndrome. Circulation 108 (2003) 1541
8. McConnell J.D., Roehrborn C.G., Bautista O.M., et al. The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. N Engl J Med 349 (2003) 2387
9. Roehrborn C.G., McConnell J.D., Lieber M., et al. Serum prostate-specific antigen concentration is a powerful predictor of acute urinary retention and need for surgery in men with clinical benign prostatic hyperplasia. Urology 53 (1999) 473
10. Soygur T., Kupeli B., Aydos K., et al. Effect of obesity on prostatic hyperplasia: its relation to sex steroid levels. Int Urol Nephrol 28 (1996) 55
11. Parsons J.K., Carter H.B., Partin A.W., et al. Metabolic factors associated with benign prostatic hyperplasia. J Clin Endocrinol Metab 91 (2006) 2562
12. Joseph M.A., Wei J.T., Harlow S.D., et al. Relationship of serum sex-steroid hormones and prostate volume in African American men. Prostate 53 (2002) 322
13. Lee S., Min H.G., Choi S.H., et al. Central obesity as a risk factor for prostatic hyperplasia. Obesity (Silver Spring) 14 (2006) 172
14. Sarma A.V., Jaffe C.A., Schottenfeld D., et al. Insulin-like growth factor-1, insulin-like growth factor binding protein-3, and body mass index: clinical correlates of prostate volume among Black men. Urology 59 (2002) 362
15. Freedland S.J., Platz E.A., Presti Jr. J.C., et al. Obesity, serum prostate specific antigen and prostate size: implications for prostate cancer detection. J Urol 175 (2006) 500
16. Giovannucci E., Rimm E.B., Chute C.G., et al. Obesity and benign prostatic hyperplasia. Am J Epidemiol 140 (1994) 989
17. Dahle S.E., Chokkalingam A.P., Gao Y.T., et al. Body size and serum levels of insulin and leptin in relation to the risk of benign prostatic hyperplasia. J Urol 168 (2002) 599
18. Kristal A.R., Arnold K.B., Schenk J.M., et al. Race/ethnicity, obesity, health related behaviors and the risk of symptomatic benign prostatic hyperplasia: results from the Prostate Cancer Prevention Trial. J Urol 177 (2007) 1395
19. Zucchetto A., Tavani A., Dal Maso L., et al. History of weight and obesity through life and risk of benign prostatic hyperplasia. Int J Obes (Lond) 29 (2005) 798
20. Burke J.P., Rhodes T., Jacobson D.J., et al. Association of anthropometric measures with the presence and progression of benign prostatic hyperplasia. Am J Epidemiol 164 (2006) 41
21. Fritschi L., Tabrizi J., Leavy J., et al. Risk factors for surgically treated benign prostatic hyperplasia in Western Australia. Public Health 121 (2007) 781
22. Gupta A., Gupta S., Pavuk M., et al. Anthropometric and metabolic factors and risk of benign prostatic hyperplasia: a prospective cohort study of Air Force veterans. Urology 68 (2006) 1198
23. Rohrmann S., Smit E., Giovannucci E., et al. Associations of obesity with lower urinary tract symptoms and noncancer prostate surgery in the Third National Health and Nutrition Examination Survey. Am J Epidemiol 159 (2004) 390
24. Seim A., Hoyo C., Ostbye T., et al. The prevalence and correlates of urinary tract symptoms in Norwegian men: the HUNT study. BJU Int 96 (2005) 88
25. Haidinger G., Temml C., Schatzl G., et al. Risk factors for lower urinary tract symptoms in elderly men. Eur Urol 37 (2000) 413
26. Joseph M.A., Harlow S.D., Wei J.T., et al. Risk factors for lower urinary tract symptoms in a population-based sample of African-American men. Am J Epidemiol 157 (2003) 906
27. Wong S.Y., Woo J., Hong A., et al. Risk factors for lower urinary tract symptoms in southern Chinese men. Urology 68 (2006) 1009
28. Gann P.H., Hennekens C.H., Longcope C., et al. A prospective study of plasma hormone levels, nonhormonal factors, and development of benign prostatic hyperplasia. Prostate 26 (1995) 40
29. Platz E.A., Kawachi I., Rimm E.B., et al. Physical activity and benign prostatic hyperplasia. Arch Intern Med 158 (1998) 2349
30. Meigs J.B., Mohr B., Barry M.J., et al. Risk factors for clinical benign prostatic hyperplasia in a community-based population of healthy aging men. J Clin Epidemiol 54 (2001) 935
31. Hong J., Kwon S., Yoon H., et al. Risk factors for benign prostatic hyperplasia in South Korean men. Urol Int 76 (2006) 11
32. Dal Maso L., Zucchetto A., Tavani A., et al. Lifetime occupational and recreational physical activity and risk of benign prostatic hyperplasia. Int J Cancer 118 (2006) 2632
33. Rohrmann S., Crespo C.J., Weber J.R., et al. Association of cigarette smoking, alcohol consumption and physical activity with lower urinary tract symptoms in older American men: findings from the third National Health and Nutrition Examination Survey. BJU Int 96 (2005) 77
34. Parsons J.K., and Kashefi C. Physical activity, benign prostatic hyperplasia, and lower urinary tract symptoms. Eur Urol 53 (2008) 1228
35. Ogden C.L., Carroll M.D., Curtin L.R., et al. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 295 (2006) 1549
36. Public health and aging: trends in aging-United States and worldwide. MMWR Morb Mortal Wkly Rep 52 (2003) 101
37. Furukawa S., Fujita T., Shimabukuro M., et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 114 (2004) 1752
38. Nickel J.C., Downey J., Young I., et al. Asymptomatic inflammation and/or infection in benign prostatic hyperplasia. BJU Int 84 (1999) 976
39. Theyer G., Kramer G., Assmann I., et al. Phenotypic characterization of infiltrating leukocytes in benign prostatic hyperplasia. Lab Invest 66 (1992) 96
40. Anim J.T., Udo C., and John B. Characterisation of inflammatory cells in benign prostatic hyperplasia. Acta Histochem 100 (1998) 439
41. Di Silverio F., Gentile V., De Matteis A., et al. Distribution of inflammation, pre-malignant lesions, incidental carcinoma in histologically confirmed benign prostatic hyperplasia: a retrospective analysis. Eur Urol 43 (2003) 164
42. Rohrmann S., De Marzo A.M., Smit E., et al. Serum C-reactive protein concentration and lower urinary tract symptoms in older men in the Third National Health and Nutrition Examination Survey (NHANES III). Prostate 62 (2005) 27
43. St Sauver J.L., Jacobson D.J., McGree M.E., et al. Protective association between nonsteroidal antiinflammatory drug use and measures of benign prostatic hyperplasia. Am J Epidemiol 164 (2006) 760